Continuing Education

Background: Homelessness being one of the independent risks for cardiovascular disease (CVD), we explored the burden of CVD risk factors

Background: Prior studies demonstrate a higher prevalence of pulmonary hypertension (PH) and more severe hemodynamics in patients with higher body

Background: Effective lipid lowering therapy reduces deaths due to atherosclerotic vascular disease (ASCVD). Proprotein convertase subtilsin/kexin type 9 inhibitor (PCSK9i)

Background: Heart failure (HF) plays a role in more than 10% of deaths annually in America. Due to high economic

Background: While the US FDA has cleared wearable device software for the detection of irregular rhythms suggestive of atrial fibrillation,

Currently, 6 million Americans suffer from congestive heart failure (CHF). The economic burden of the disease continues to rise with

Introduction/ Objective: Stroke patients are at high risk for swallowing complications which leads many patients to receive a temporary or

Objectives: In patients with chronic heart failure (HF), self-care improves the quality of life and prevents hospitalizations. The health confidence

Background: Statin therapy has been shown to prevent the development of transplant coronary artery disease (TCAD) in heart transplant (HT)

Background: While the safety and efficacy of tafamidis are described in clinical trials, data on its real-world application are lacking.